98 related articles for article (PubMed ID: 3351840)
1. Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
McConkey B; Situnayake RD
J Rheumatol; 1988 Jan; 15(1):46-50. PubMed ID: 3351840
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
3. Treatment of early rheumatoid arthritis with rifampicin.
Cox NL; Prowse MV; Maddison MC; Maddison PJ
Ann Rheum Dis; 1992 Jan; 51(1):32-4. PubMed ID: 1540033
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
[TBL] [Abstract][Full Text] [Related]
5. [Renal tuberculosis treated with rifampicin, isoniazid and ofloxacin].
Alberte A; Martínez-Sagarra JM; Estébanez MJ; Pascual PP
Enferm Infecc Microbiol Clin; 1992 Apr; 10(4):216-9. PubMed ID: 1606225
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
7. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
Kuz'min AV; Vasil'eva IA; Chernousova LN
Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
[TBL] [Abstract][Full Text] [Related]
8. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
9. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
10. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
12. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
13. Thai drug-resistant tuberculosis predictive scores.
Boonsarngsuk V; Tansirichaiya K; Kiatboonsri S
Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
[TBL] [Abstract][Full Text] [Related]
14. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
Brändli O; Dreher D; Morger D
Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
Pilheu JA; Galati MR; Yunis AS; De Salvo MC; Negroni R; García Fernández JC; Mingolla L; Rubio MC; Masana M; Acevedo C
Medicina (B Aires); 1989; 49(1):43-7. PubMed ID: 2698437
[TBL] [Abstract][Full Text] [Related]
16. [The comparison of clinical features between early rheumatoid arthritis and established rheumatoid arthritis].
Furuta E; Suenaga Y; Hashimoto M; Shiokawa S; Nonaka S; Wada T; Yasuda M; Shingu M; Nobunaga M
Ryumachi; 1994 Jun; 34(3):594-600. PubMed ID: 8052925
[TBL] [Abstract][Full Text] [Related]
17. Treatment of tuberculous meningitis: role of short-course chemotherapy.
Phuapradit P; Vejjajiva A
Q J Med; 1987 Mar; 62(239):249-58. PubMed ID: 3659258
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of rifampicin-isoniazid treatment in tuberculous meningitis].
Hermida-Escobedo C; Peredo-Velarde MA
Rev Latinoam Microbiol; 1985; 27(4):277-81. PubMed ID: 3837280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
